Amarin CORP Plcuk 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Amarin Corporation plc reports a 7% decrease in total revenue for 2025, driven by declining U.S. VASCEPA sales amidst generic competition, while advancing international commercialization and restructuring efforts.
NASDAQ
10-K: Amarin Reports Fiscal Year 2024 Results, Navigates Generic Competition and Expands Global Reach
Amarin Corporation reports its 2024 financial results, highlighting challenges from U.S. generic competition and progress in European and international markets.
NASDAQ
Amarin Corporation plc has appointed Jonathan Provoost as Executive Vice President, Chief Legal and Compliance Officer, and filed its annual report on Form 10-K, detailing its financial performance and strategic initiatives.